Paper
24 March 2023 The genes that contribute to bipolar disorder and its genetic therapy
Chenjun Su
Author Affiliations +
Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 126112Z (2023) https://doi.org/10.1117/12.2669373
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom
Abstract
Bipolar disorder, also called BD, is a kind of severe and frequent mental disease, with considerable morbidity and mortality. It is quite difficult to find out effective way to treat it due to its relatively high complexity compared to other similar diseases. There are different contributors that can lead to BD. Among these, genetic factors dominate. Therefore, it is not useful enough to treat BD with medicine like lithium and lurasidone, which can be used to treat other mental diseases like manic and depression. In genome, there are quite a few genes, including BDNF, 5-HTTLPR, HLA-G and NCAN, etc., associated with bipolar disorder, which provides us with new direction to the treatment. Additionally, genetic therapy seems to show no side effects on patients, providing a better chance in treatment. In this review, it will be discussed that what the genes that lead to BD are and how they contribute to it and the genetic therapy.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Chenjun Su "The genes that contribute to bipolar disorder and its genetic therapy", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 126112Z (24 March 2023); https://doi.org/10.1117/12.2669373
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Mental disorders

Genetics

Diseases and disorders

Brain

Neurons

Proteins

Neurological disorders

RELATED CONTENT

The causes of schizophrenia in adolescents
Proceedings of SPIE (March 24 2023)
The role of NRG1 in schizophrenia
Proceedings of SPIE (March 24 2023)
Current treatment of autism spectrum disorder
Proceedings of SPIE (March 24 2023)
Diagnosis and treatment for Huntington’s disease
Proceedings of SPIE (September 07 2023)

Back to Top